| Entry |
|
|---|
| Name |
Netoglitazone (USAN/INN)
|
|---|
| Formula |
C21H16FNO3S
|
|---|
| Exact mass |
381.0835
|
|---|
| Mol weight |
381.42
|
|---|
| Structure |
     |
|---|
| Activity |
Antidiabetic;
Orally-administered insulin action enhancer to lower the plasma glucose in patients with non-insulin dependent diabetes mellitus [Type II]
|
|---|
| Target |
peroxisome proliferator-activated receptor (PPAR) gamma modulator [HSA: 5468] [KO: K08530] |
|---|
| Pathway |
|
|---|
| Structure map |
| Peroxisome proliferator-activated receptor (PPAR) agonists |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
peroxisome proliferator-activated receptor (PPAR) gamma [HSA:5468] [KO:K08530]
Netoglitazone
D05150 Netoglitazone (USAN/INN)
 |
|---|
| Other DBs |
CAS: 161600-01-7 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 27
1 C8x C 24.5000 -22.2600
2 C8y C 24.5000 -23.6600
3 C8x C 25.7124 -24.3600
4 C8y C 26.9249 -23.6600
5 C8y C 26.9249 -22.2600
6 C8x C 25.7124 -21.5600
7 C8x C 28.1373 -24.3600
8 C8x C 29.3497 -23.6600
9 C8y C 29.3497 -22.2600
10 C8x C 28.1373 -21.5600
11 C1b C 30.5473 -21.5685
12 C1y C 31.7356 -22.2545
13 C5x C 31.7136 -23.6600
14 N1x N 33.0404 -24.1147
15 C5x C 33.8828 -22.9933
16 S2x S 33.0767 -21.8456
17 O5x O 35.2789 -22.9456
18 O5x O 30.5657 -24.4666
19 O2a O 23.2876 -24.3600
20 C1b C 22.0921 -23.6696
21 C8y C 20.9047 -24.3551
22 C8y C 19.7135 -23.6671
23 C8x C 18.5010 -24.3669
24 C8x C 18.5008 -25.7669
25 C8x C 19.6920 -26.4549
26 C8x C 20.9045 -25.7551
27 X F 19.7135 -22.2602
BOND 30
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 14 15 1
17 15 16 1
18 12 16 1
19 15 17 2
20 13 18 2
21 2 19 1
22 19 20 1
23 20 21 1
24 21 22 2
25 22 23 1
26 23 24 2
27 24 25 1
28 25 26 2
29 21 26 1
30 22 27 1
|
|---|
